The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have ...

M1 disease detected with PSMA-PET in 46 percent of patients with high-risk, nonmetastatic hormone-sensitive prostate cancer.

9, 2025 — Researchers have shown that a test called ORACLE can predict lung cancer ... cancers on imaging scans, in a breakthrough that could help medical ... In Five Cancer Types, Prevention ...

Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...

Cancer patients are skipping scans because they’re too expensive. Picture: Supplied “It’s that double whammy of a cancer diagnosis impacting on people’s ability to work at the same time as ...

Immunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer. Immunotherapy has been shown to improve survival in ...

The mRNA-4157 cancer vaccine, combined with Keytruda, produced anti-tumor responses in NSCLC and melanoma, indicating potential for neoantigen therapies. SABR is a viable curative treatment for ...

that binds to prostate cancer cells, making them visible on PET scans. Unlike conventional imaging, which provides only anatomical details, PSMA-PET offers functional imaging that reveals the ...

that binds to prostate cancer cells, making them visible on PET scans. Unlike conventional imaging, which provides only anatomical details, PSMA-PET offers functional imaging that reveals the cancer’s ...

Paul Nelson, 72, from Birkenhead, had no symptoms at all when he went for a TLHC check but a scan found lung cancer. Recalling the moment he was diagnosed, Mr Nelson said: “That first scan gave ...

One person who has benefited from an early cancer diagnosis is Paul Nelson. The 72-year-old pensioner from Birkenhead had no symptoms at all when he went for a TLHC but the scan found lung cancer.